RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,360 | -99.4% | 19,200 | -97.1% | 0.00% | -100.0% |
| Q2 2022 | $564,000 | -68.5% | 662,593 | +104.1% | 0.00% | -60.0% |
| Q1 2022 | $1,789,000 | -35.6% | 324,661 | +13.1% | 0.01% | -16.7% |
| Q4 2021 | $2,778,000 | -37.0% | 286,967 | +16.4% | 0.01% | -40.0% |
| Q3 2021 | $4,409,000 | +21.5% | 246,566 | +65.9% | 0.01% | +25.0% |
| Q2 2021 | $3,629,000 | +2196.8% | 148,656 | +616.2% | 0.01% | – |
| Q4 2020 | $158,000 | -33.1% | 20,755 | -55.9% | 0.00% | -100.0% |
| Q3 2020 | $236,000 | -43.4% | 47,091 | -32.5% | 0.00% | -50.0% |
| Q2 2020 | $417,000 | +4.5% | 69,719 | -22.3% | 0.00% | -33.3% |
| Q1 2020 | $399,000 | – | 89,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
| Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
| Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
| Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
| ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
| Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
| Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
| Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
| FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |